Merck News

Artificial intelligence is being used to tailor cancer treatments and identify new uses for existing medicines, with some technologies already benefiting patien

Ethics watchdogs are awaiting the late financial disclosure report from Health Secretary RFK Jr., which may reveal earnings from a vaccine-related lawsuit again

Cipla's US unit has partnered with China's Qilu Pharmaceutical to license QL2107, a biosimilar of Merck's cancer drug Keytruda, for commercialization in the US,

A personalized cancer vaccine developed by Moderna and Merck has shown success in a final-stage melanoma trial. Researchers are hopeful this approach could be u

Merck and Moderna announced that their cancer vaccine for melanoma successfully met its primary and key secondary endpoints in a Phase 3 trial, showing improved

A personalized cancer vaccine developed by Merck and Moderna shows promise for melanoma patients, significantly reducing cancer recurrence when combined with Ke

Moderna and Merck announced that a new personalized mRNA vaccine significantly reduced the risk of melanoma recurrence and spread in a late-stage trial, marking

Merck and Moderna announced that their personalized mRNA vaccine successfully prevented melanoma recurrence in high-risk patients during a late-stage trial, tho

Moderna and Merck's personalized mRNA cancer vaccine has met its primary goals in a Phase 3 trial for high-risk melanoma, marking a significant breakthrough and

Moderna and Merck have announced that their experimental mRNA vaccine has shown success in preventing the return and spread of melanoma in high-risk patients. T

Moderna's stock surged by 120% following positive Phase 3 trial results for its mRNA cancer vaccine when combined with Merck's Keytruda, offering new hope for m

Moderna's stock surged after the company and Merck announced "landmark moment" study results for their melanoma vaccine trial, showing significant progress in t

Moderna and Merck have reported promising results from a late-stage trial combining Moderna's mRNA therapy, intismeran, with Merck's Keytruda for melanoma patie

Moderna shares soared nearly 100% after its mRNA vaccine, developed with Merck, showed success in a large trial for skin cancer. Interim results indicated the t

Moderna's share price has doubled following successful trial results for its melanoma cancer vaccine, which is being developed in collaboration with Merck.

Stanford University is operating a virtual biotech with 37,000 AI agents, and one of its AI-designed drug candidates has been independently confirmed by Merck.

Lupin Limited has launched its Sugammadex Injection in the United States after receiving approval from the US Food and Drug Administration. The company claims i

Merck is taking steps to ensure access to a new HIV prevention pill, with companies in Africa and India set to produce generic versions costing as little as $5

The FDA has approved Merck's new once-daily cholesterol pill, Lipfendra (enlicitide), marking it as the first oral PCSK9 inhibitor available. This approval intr

The FDA has approved a new Merck pill, Lipfendra, which drastically reduces cholesterol by blocking the PCSK9 liver protein, previously only achievable with exp

Drugmaker Merck announced that its new daily pill, Lipfendra, has received FDA approval for treating high LDL cholesterol. Lipfendra, a PCSK9 inhibitor, can be

TIME and Statista have identified America's Best Companies of 2026, ranking 1000 top-performing firms based on employee satisfaction, financial performance, and